510(k) device
Focal One®
Edap Technomed, Inc. · High Intensity Ultrasound System For Prostate Tissue Ablation (PLP, Class II) · First FDA decision Jun 7, 2018, newest Nov 19, 2025Prostate cancer
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
359
Naming "Focal One"
MAUDE reports
3
Brand "Focal One", since 2015
PubMed studies
55
Mentioning "Focal One"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Focal One®
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Focal One®510(k)
K251910 · Decided Nov 19, 2025 · 152 days after receipt
Device type: High Intensity Ultrasound System For Prostate Tissue Ablation (PLP) · GI, Urology & Nephrology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cryosurgery Ablation for Prostate CancerNational analysisReview closedCAG-00031NUpdated Sep 14, 2026
- Laser Ablation of the ProstateLocal determinationIn effectL34090CGS Administrators, LLCUpdated Mar 25, 2026
- Transurethral Waterjet Ablation of the ProstateLocal determinationIn effectL38705Noridian Healthcare Solutions, LLCUpdated Feb 23, 2026
- Transurethral Waterjet Ablation of the ProstateLocal determinationIn effectL38549Palmetto GBAUpdated Oct 24, 2025
- Transurethral Waterjet Ablation of the ProstateLocal determinationIn effectL38682WPS Insurance CorporationUpdated Oct 21, 2025
- Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for TremorProposed local determinationProposedDL37421National Government Services, Inc.Updated Sep 18, 2025
- Transurethral Waterjet Ablation of the ProstateLocal determinationIn effectL38726First Coast Service Options, Inc.Updated Mar 14, 2025
- Transurethral Waterjet Ablation of the ProstateLocal determinationIn effectL38712Novitas Solutions, Inc.Updated Mar 14, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "Focal One", any status and sponsor, newest update first.
University of UtahAcademic, hospital or other
NCT05291507 · 34 participants (planned) · Start Jan 23, 2023 · Primary completion Jan 2027
Device: Muse MRgFUS System · For: Breast Cancer
Sites: Salt Lake City, Utah
358 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Focal One", and for the whole product code for context.
This brand
3 reports: 0 malfunction, 3 injury, 0 death
Whole product code PLP
33 reports: 1 malfunction, 31 injury, 1 death
Newest reports for this brand
- FOCAL ONE HIFU SYSTEMInjury
MW5184785 · Received Mar 5, 2026
Device type: High Intensity Ultrasound System For Prostate Tissue Ablation (PLP)
Patient problem as coded: Hematuria; Fibrosis; Cancer; Erectile Dysfunction; Urinary Incontinence
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Focal One"[tiab]. The summary above synthesizes these.
- Passive Elastography for Clinical HIFU Lesion Detection.
Payen T, Crouzet S, Guillen N, et al. · IEEE Trans Med Imaging · 2024Research Support, Non-U.S. Gov't
- Pattern Electroretinogram Detects Localized Glaucoma Defects.
Salgarello T, Giudiceandrea A, Calandriello L, et al. · Transl Vis Sci Technol · 2018
- Outcomes of partial gland ablation using high intensity focused ultrasound for prostate cancer.
Hong SK, Lee H · Urol Oncol · 2022Research Support, Non-U.S. Gov't
- [HIFU: Best Practices for Optimal Performance].
Salomon G, Heckmann N, Hohenhorst JL, et al. · Aktuelle Urol · 2026Review, English Abstract
- Role of long noncoding RNAs; BDNF-AS and 17A and their relation to GABAergic dysfunction in Egyptian epileptic patients.
Zayed AA, Seleem MM, Darwish HA, et al. · Metab Brain Dis · 2023Research Support, Non-U.S. Gov't
- Misdiagnoses in children with dopa-responsive dystonia.
Jan MM · Pediatr Neurol · 2004Case Reports, Review
- [Oncological and functional results of focal treatment of localized prostate cancer with HIFU].
Debard C, Margue G, Klein C, et al. · Prog Urol · 2023Multicenter Study, English Abstract
- Use of hyperbaric oxygen therapy in pediatric neuro-oncology: a single institutional experience.
Aghajan Y, Grover I, Gorsi H, et al. · J Neurooncol · 2019
- Transition to adulthood with a bladder augmentation: histopathologic concerns.
Mammadov E, Dervisoglu S, Elicevik M, et al. · Int Braz J Urol · 2017
- Primary cutaneous EBV+ extranodal NK/T-cell lymphoma of gamma/delta T-cell lineage in the posttransplantation setting.
Williams JF, Lucas FM, Carrasco RD, et al. · J Cutan Pathol · 2024Case Reports
- FocalONE high-intensity focused ultrasound for localized prostate cancer: A systematic review of oncologic outcomes, functional preservation, and technological evolution.
Eskandar K · Actas Urol Esp (Engl Ed) · 2025Systematic Review
- Traumatic epididymitis: evaluation with color Doppler sonography.
Gordon LM, Stein SM, Ralls PW · AJR Am J Roentgenol · 1996
Other devices of this type
Also filed under product code PLP.
- TULSA-PRO SystemProfound Medical, Inc. · 510(k) 2023
- Exablate Model 2100V1Insightec, Ltd. · 510(k) 2023
- Tulsa Pro System (Pad-105)Profound Medical, Inc. · 510(k) 2024
- Ablatherm FusionEdap Technomed, Inc. · 510(k) 2017
- SonablateSonacare Medical, LLC · 510(k) 2016
- Ablatherm Integrated ImagingEdap Technomed, Inc. · 510(k) 2015
- Sonablate 450Sonacare Medical, LLC · De Novo 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.